Q2 2026 Holdings
Filed 2026-08-14 | 14 holdings | $731.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $452.7M | 6,371,669 | 61.9% |
| Nuvation Bio Inc.(NUVB) | COM | 67080N101 | $147.4M | 25,954,439 | 20.1% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $22.6M | 3,917,299 | 3.1% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $21.4M | 4,041,736 | 2.9% |
| Upstream Bio Inc.(UPB) | COM | 91678A107 | $18.9M | 2,724,868 | 2.6% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $14.3M | 464,779 | 2.0% |
| Equillium Inc.(EQ) | COM | 29446K106 | $14.2M | 4,447,308 | 1.9% |
| Revolution Medicines Inc(nsm)(RVMD) | COM | 76155X100 | $9.9M | 52,667 | 1.3% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $9.7M | 692,050 | 1.3% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $6.7M | 3,800,702 | 0.9% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $6.4M | 1,323,327 | 0.9% |
| Newamsterdam Pharma Co NV(NAMS) | COM | N62509109 | $6.0M | 176,887 | 0.8% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | COM | 747324101 | $983.7K | 326,810 | 0.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $625.2K | 20,000 | 0.1% |